NOVAREX Co.Ltd (194700) - Net Assets
Based on the latest financial reports, NOVAREX Co.Ltd (194700) has net assets worth ₩254.64 Billion KRW (≈ $172.57 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩359.55 Billion ≈ $243.67 Million USD) and total liabilities (₩104.91 Billion ≈ $71.10 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 194700 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩254.64 Billion |
| % of Total Assets | 70.82% |
| Annual Growth Rate | 21.5% |
| 5-Year Change | 82.32% |
| 10-Year Change | 470.72% |
| Growth Volatility | 11.72 |
NOVAREX Co.Ltd - Net Assets Trend (2015–2025)
This chart illustrates how NOVAREX Co.Ltd's net assets have evolved over time, based on quarterly financial data. Also explore balance sheet size of NOVAREX Co.Ltd for the complete picture of this company's asset base.
Annual Net Assets for NOVAREX Co.Ltd (2015–2025)
The table below shows the annual net assets of NOVAREX Co.Ltd from 2015 to 2025. For live valuation and market cap data, see NOVAREX Co.Ltd stock valuation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | ₩254.64 Billion ≈ $172.57 Million |
+15.61% |
| 2024-12-31 | ₩220.26 Billion ≈ $149.27 Million |
+9.90% |
| 2023-12-31 | ₩200.42 Billion ≈ $135.82 Million |
+10.50% |
| 2022-12-31 | ₩181.37 Billion ≈ $122.91 Million |
+29.86% |
| 2021-12-31 | ₩139.67 Billion ≈ $94.65 Million |
+20.81% |
| 2020-12-31 | ₩115.61 Billion ≈ $78.35 Million |
+25.95% |
| 2019-12-31 | ₩91.79 Billion ≈ $62.21 Million |
+16.30% |
| 2018-12-31 | ₩78.93 Billion ≈ $53.49 Million |
+52.14% |
| 2017-12-31 | ₩51.88 Billion ≈ $35.16 Million |
+16.27% |
| 2016-12-31 | ₩44.62 Billion ≈ $30.24 Million |
+22.89% |
| 2015-12-31 | ₩36.31 Billion ≈ $24.61 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to NOVAREX Co.Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 960.5% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₩216.62 Billion | 85.58% |
| Other Components | ₩36.50 Billion | 14.42% |
| Total Equity | ₩253.12 Billion | 100.00% |
NOVAREX Co.Ltd Competitors by Market Cap
The table below lists competitors of NOVAREX Co.Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
CHC Healthcare Group
TW:4164
|
$178.76 Million |
|
Dynamix Corporation
NASDAQ:ETHM
|
$178.78 Million |
|
Vina San Pedro
SN:VSPT
|
$178.80 Million |
|
Parrot
PA:PARRO
|
$178.84 Million |
|
FineTek Co Ltd
TWO:4549
|
$178.69 Million |
|
Wei Chih Steel Industrial Co Ltd
TW:2028
|
$178.65 Million |
|
TIDEWATER RENEWABLES LTD
F:7GZ
|
$178.57 Million |
|
Amrutanjan Health Care Limited
NSE:AMRUTANJAN
|
$178.52 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in NOVAREX Co.Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 219,256,138,080 to 253,123,794,050, a change of 33,867,655,970 (15.4%).
- Net income of 35,416,064,440 contributed positively to equity growth.
- Dividend payments of 3,540,443,200 reduced retained earnings.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩35.42 Billion | +13.99% |
| Dividends Paid | ₩3.54 Billion | -1.4% |
| Other Changes | ₩1.99 Billion | +0.79% |
| Total Change | ₩- | 15.45% |
Book Value vs Market Value Analysis
This analysis compares NOVAREX Co.Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.04x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 5.19x to 1.04x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | ₩2870.45 | ₩14900.00 | x |
| 2017-12-31 | ₩3331.82 | ₩14900.00 | x |
| 2018-12-31 | ₩4875.78 | ₩14900.00 | x |
| 2019-12-31 | ₩5670.58 | ₩14900.00 | x |
| 2020-12-31 | ₩7142.03 | ₩14900.00 | x |
| 2021-12-31 | ₩8628.31 | ₩14900.00 | x |
| 2022-12-31 | ₩10231.49 | ₩14900.00 | x |
| 2023-12-31 | ₩11311.17 | ₩14900.00 | x |
| 2024-12-31 | ₩12385.80 | ₩14900.00 | x |
| 2025-12-31 | ₩14298.99 | ₩14900.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently NOVAREX Co.Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 13.99%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 8.76%
- • Asset Turnover: 1.12x
- • Equity Multiplier: 1.42x
- Recent ROE (13.99%) is below the historical average (16.19%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2015 | 26.63% | 11.69% | 1.47x | 1.55x | ₩6.04 Billion |
| 2016 | 20.62% | 11.93% | 1.28x | 1.35x | ₩4.74 Billion |
| 2017 | 15.62% | 10.02% | 1.13x | 1.38x | ₩2.92 Billion |
| 2018 | 12.02% | 8.84% | 1.01x | 1.35x | ₩1.60 Billion |
| 2019 | 16.02% | 9.25% | 1.03x | 1.68x | ₩5.53 Billion |
| 2020 | 21.75% | 11.28% | 1.03x | 1.86x | ₩13.58 Billion |
| 2021 | 18.90% | 9.47% | 1.09x | 1.82x | ₩12.43 Billion |
| 2022 | 11.03% | 7.10% | 1.04x | 1.49x | ₩1.87 Billion |
| 2023 | 11.01% | 7.29% | 1.14x | 1.32x | ₩2.01 Billion |
| 2024 | 10.50% | 7.73% | 1.03x | 1.32x | ₩1.09 Billion |
| 2025 | 13.99% | 8.76% | 1.12x | 1.42x | ₩10.10 Billion |
Industry Comparison
This section compares NOVAREX Co.Ltd's net assets metrics with peer companies in the Packaged Foods industry.
Industry Context
- Industry: Packaged Foods
- Average net assets among peers: $624,762,189,955
- Average return on equity (ROE) among peers: 2.47%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| NOVAREX Co.Ltd (194700) | ₩254.64 Billion | 26.63% | 0.41x | $178.75 Million |
| Daehan Flour Mills Co Ltd (001130) | $238.84 Billion | 11.11% | 1.02x | $174.98 Million |
| Daesang Corp (001680) | $1.45 Trillion | 6.58% | 1.42x | $486.05 Million |
| Daesang Corp Preference Shares (001685) | $1.32 Trillion | 6.28% | 1.41x | $15.68 Million |
| Korea Ind (002140) | $88.76 Billion | 5.76% | 1.06x | $47.32 Million |
| Choheung (002600) | $149.64 Billion | 0.24% | 1.63x | $59.77 Million |
| Sam Yang Foods (003230) | $54.47 Billion | 7.75% | 2.83x | $5.05 Billion |
| Daejoo Inc (003310) | $50.50 Billion | 5.36% | 0.67x | $82.87 Million |
| Harim Holdings Co. Ltd (003380) | $2.10 Trillion | 14.57% | 4.53x | $864.77 Million |
| Hansung Ent (003680) | $54.58 Billion | -22.33% | 2.91x | $19.75 Million |
| Namyang Dairy (003920) | $737.95 Billion | -10.63% | 0.22x | $209.00 Million |
About NOVAREX Co.Ltd
NOVAREX Co.,Ltd. manufactures, wholesales, and retails health and functional foods in South Korea and internationally. It offers lactic acid bacteria, omega-3, icle time, eye health, diet, boswellia, and lutein and zeaxanthin, as well as vitamin and mineral products in the form of tablets, soft and hard capsules, powder, liquid, gel, and jellies. The company was formerly known as Health Science C… Read more